Skip to main content
. 2016 Sep 14;11(9):e0161715. doi: 10.1371/journal.pone.0161715

Table 1. Clinical characteristics of study patients.

Sinus Rhythm Paroxysmal AF Persistent AF P Value
(n = 527) (n = 28) (n = 32)
Age, years 64 ± 11 70 ± 10 70 ± 10 0.001
Female 178 (34%) 10 (36%) 9 (28%) 0.80
Obesity 237 (45%) 16 (57%) 15 (47%) 0.45
Diabetes mellitus 294 (56%) 16 (57%) 16 (50%) 0.82
Hypertension 426 (80%) 25 (89%) 27 (84%) 0.50
Dyslipidemia 434 (82%) 20 (71%) 22 (69%) 0.06
Myocardial infarction 111 (21%) 10 (36%) 5 (16%) 0.13
Heart failure 29 (6%) 10 (36%) 12 (38%) <0.001
Valvular heart disease 28 (5%) 4 (14%) 4 (13%) 0.03
Renal impairment 110 (21%) 10 (36%) 12 (38%) 0.02
Cigarette smoking 75 (14%) 3 (11%) 1 (3%) 0.19
Stroke 20 (4%) 2 (7%) 5 (16%) 0.01
Medications
Warfarin 10 (2%) 5 (18%) 24 (75%) <0.001
Antiplatelet 392 (74%) 20 (71%) 10 (31%) <0.001
Beta-blocker 245 (47%) 18 (64%) 22 (69%) 0.01
Antiarrhythmic 3 (0.6%) 11 (39%) 5 (16%) <0.001
ACEi or ARB 366 (69%) 24 (86%) 21 (66%) 0.15
Diuretic 183 (35%) 17 (61%) 21 (66%) <0.001
Statin 387 (73%) 20 (71%) 17 (53%) 0.05
Insulin 145 (28%) 4 (14%) 6 (19%) 0.20
Physical Parameters
Heart rate, beats/min 67 ± 13 65 ± 14 79 ± 21 <0.001
Systolic BP, mmHg 133 ± 23 139 ± 21 132 ± 23 0.43
LV dysfunction 77 (15%) 7 (26%) 9 (29%) 0.05
Biochemical Parameters
Renal impairment 80 ± 28 74±29 67±24 0.02
LDL cholesterol, mmol/L 2.4 ± 1.0 2.2 ± 1.0 2.2 ± 1.0 0.36
C-reactive protein, mg/L 2.7 (1.2, 5.3) 7.3 (2.0, 11.2) 4.6 (1.3, 8.3) 0.03
Serum sRAGE, pg/ml 782 (576, 1039) 799 (583, 1033) 1190 (724, 2041) 0.001
Serum esRAGE, pg/ml 289 (192, 412) 279 (201, 433) 452 (288, 932) 0.001

Subgroup analysis:

† p <0.05 vs. sinus rhythm

‡ p <0.05 vs. paroxysmal AF.

Values are total numbers and proportion (%), mean ± SD, or median (25, 75th percentile). ACEi = angiotensin converting enzyme inhibitor; AF = atrial fibrillation; ARB = angiotensin II receptor blocker; BP = blood pressure; LDL = low-density lipoprotein; LV = left ventricular; RAGE = receptor for advanced glycation end products.